Press Overview

Thursday, November 20, 2014
Behind every good 3D-printed part is good software. Materialise works with 3D printer manufacturers to make software that connects with their line of machines, giving users the best results and streamlining the 3D printing process. The build processors provide that necessary link between software and machine, filling the role of 2D printer drivers between computers and inkjet printers.
Friday, November 14, 2014
Leuven, Belgium – November 13, 2014. Materialise NV (NASDAQ: MTLS), a leading provider of Additive Manufacturing software and of sophisticated 3D Printing solutions in the medical and industrial markets, is proud to announce the launch of a build processor for SLM Solutions 3D printers. The SLM Build Processor is now available for purchase.
Wednesday, November 12, 2014
Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing services, today announced its financial results for the third quarter ending September 30, 2014.
Tuesday, October 21, 2014
Complementary Transaction Creates One-Stop Shop for Surgical Planning Software Tools and Corresponding 3D Printed Medical Devices
Tuesday, October 21, 2014
Additive Manufacturing pioneer Materialise is proud to announce the launch of Magics19, the latest release of its leading STL file preparation software for Additive Manufacturing professionals. Focused on making your workflow as efficient as possible, Magics19 improves upon existing tools and modules and offers powerful new features to enhance your workflow capabilities. With Magics19, as with all Materialise software, the aim is to produce the most enjoyable user experience possible and to provide the best tools for 3D Printing and AM production environments.
Thursday, October 9, 2014
Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing solutions in the medical and industrial markets, has listed its 3D-printed cardiovascular HeartPrint® models as a medical device in the USA and EU markets. After years of 3D printing anatomical models for educational and research purposes, the Company addressed the need for models that can assist with diagnosing, planning and practicing complex cardiovascular procedures. This move strengthens the Company’s unique position in the market and is a natural extension of its Mimics® Innovation Suite of software for medical image processing which has an existing 510(k) clearance and CE mark.